Homepage500420 • BOM
add
Torrent Pharmaceuticals Ltd
Vorige slotkoers
₹ 2.703,70
Dag-range
₹ 2.685,00 - ₹ 2.757,80
Jaar-range
₹ 1.615,20 - ₹ 2.782,00
Beurswaarde
915,31Â mld. INR
Gem. volume
3,29K
Koers/winst
60,53
Dividendrendement
1,12%
Primaire beurs
NSE
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(INR) | dec 2023info | Wijziging j-o-j |
---|---|---|
Opbrengst | 27,32Â mld. | 9,67% |
Bedrijfskosten | 13,79Â mld. | 12,11% |
Netto inkomsten | 4,43Â mld. | 56,54% |
Netto winstmarge | 16,22 | 42,78% |
Winst per aandeel | 11,27 | 34,85% |
EBITDA | 8,22Â mld. | 20,08% |
Effectief belastingtarief | 29,79% | — |
Balans
Totale activa
Totale passiva
(INR) | dec 2023info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 7,90Â mld. | -2,59% |
Totale activa | — | — |
Totale passiva | — | — |
Totaal aandelenvermogen | 67,07 mld. | — |
Uitstaande aandelen | 338,17 mln. | — |
Koers-boekwaardeverhouding | 13,66 | — |
Rendement op activa | — | — |
Rendement op kapitaal | 14,65% | — |
Kasstroom
Nettomutatie in liquide middelen
(INR) | dec 2023info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 4,43Â mld. | 56,54% |
Operationele kasstroom | — | — |
Kasstroom uit beleggingen | — | — |
Kasstroom uit financiering | — | — |
Nettomutatie in liquide middelen | — | — |
Vrije kasstroom | — | — |
Over
Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology and pediatrics. Wikipedia
Opgericht
1959
Hoofdvestiging
Website
Werknemers
13.247